GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

S2Medical AB (publ) S2M.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.00

-5.56%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 14.4m

FY2016FY2025

Net income

−SEK 10.1m

FY2016FY2025

Free cash flow

—

FY2016FY2025

Shareholders' equity

SEK 9.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 14.4mSEK 14.9mSEK 7.0mSEK 4.7mSEK 7.7mSEK 25.6mSEK 3.1mSEK 1.5mSEK 844,000SEK 340,000
Research and development——SEK 606,114SEK 594,898SEK 385,342SEK 383,738SEK 383,738SEK 383,738SEK 383,738—
Operating income−SEK 2.7mSEK 5.8m−SEK 15.3m−SEK 27.7m−SEK 19.8m−SEK 15.1m−SEK 18.3m−SEK 10.6m−SEK 5.2m−SEK 1.0m
Net income−SEK 10.1mSEK 5.8m−SEK 22.7m−SEK 29.5m−SEK 20.1m−SEK 15.1m−SEK 18.4m−SEK 10.7m−SEK 5.4m−SEK 1.2m
Diluted earnings per share-0.010.02-0.06-0.35-0.49-1.28-1.56-1.23-0.72-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 16.9mSEK 18.1mSEK 21.4mSEK 25.3mSEK 29.7mSEK 41.2mSEK 30.7mSEK 49.1mSEK 11.2mSEK 6.4m
Cash and short-term investmentsSEK 907,000SEK 1.0mSEK 1.5mSEK 3.7mSEK 9.5mSEK 25.3mSEK 15.5mSEK 36.4mSEK 5.5mSEK 2.0m
Total liabilitiesSEK 7.0mSEK 6.3mSEK 19.7mSEK 18.2mSEK 15.0mSEK 8.5mSEK 5.6mSEK 5.5mSEK 3.8mSEK 3.7m
Debt——−SEK 2.2mSEK 231,496SEK 207,692SEK 830,769SEK 1.5mSEK 2.2mSEK 165,290—
Shareholders' equitySEK 9.9mSEK 11.8mSEK 1.7mSEK 7.1mSEK 14.7mSEK 32.8mSEK 25.1mSEK 43.5mSEK 7.4mSEK 2.8m
Shares outstanding869m366m358m84m41m12m12m9m8m912m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 675,000SEK 5.0m−SEK 16.5m−SEK 28.1m−SEK 19.7m−SEK 12.7m−SEK 17.1m−SEK 12.8m−SEK 5.8m−SEK 3.0m
Capital spending−SEK 675,000−SEK 634,000−SEK 1.2m−SEK 1.9m−SEK 3.1m−SEK 2.0m−SEK 3.1m−SEK 2.6m−SEK 475,000−SEK 611,000
Free cash flow—SEK 4.4m−SEK 17.7m−SEK 30.0m−SEK 22.8m−SEK 14.7m−SEK 20.2m−SEK 15.3m−SEK 6.3m−SEK 3.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 3.9mSEK 3.9mSEK 4.2mSEK 4.2mSEK 6.9mSEK 3.9mSEK 3.8mSEK 3.8m
Operating incomeSEK 94,000SEK 94,000−SEK 1.1m−SEK 1.1m−SEK 542,000−SEK 271,000−SEK 1.5m−SEK 1.5m
Net incomeSEK 93,000SEK 93,000−SEK 5.1m−SEK 5.1mSEK 163,000SEK 81,500−SEK 2.4m−SEK 1.5m
Diluted earnings per share0.000.00-0.01-0.010.000.00-0.01-0.00
Cash from operations————SEK 1.0m—SEK 2.0mSEK 2.0m
Capital spending——−SEK 2.0m—−SEK 1.0m———
Free cash flow————SEK 0———
Total assetsSEK 16.9mSEK 16.9mSEK 16.9mSEK 16.9mSEK 26.0mSEK 26.0mSEK 18.1mSEK 25.4m
Cash and short-term investmentsSEK 564,000SEK 564,000SEK 906,868SEK 906,868SEK 1.3mSEK 1.3mSEK 1.0mSEK 1.0m
Shareholders' equitySEK 10.1mSEK 10.1mSEK 9.9mSEK 9.9mSEK 18.9mSEK 18.9mSEK 11.8mSEK 18.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue45.4%-10.9%25.1%
Operating income-54.1%-29.2%—
Net income-30.0%-7.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin10.6%-97.4%-100.7%-134.8%
Net margin-14.8%-138.1%-123.5%-156.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-0.90.7-0.6-0.1-0.2-0.1-0.1-0.5
Price to sales0.70.32.00.30.60.10.73.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.